Katherine Lorraine Grady, MSW, CAPSW - Medicare Clinical Social Worker in Ripon, WI

Katherine Lorraine Grady, MSW, CAPSW is a medicare enrolled "Social Worker - Clinical" provider in Ripon, Wisconsin. She graduated from medical school in 2013 and has 11 years of diverse experience with area of expertise as Clinical Social Worker. She is a member of the group practice Agnesian Healthcare Inc and her current practice location is 845 Parkside St, Ripon, Wisconsin. You can reach out to her office (for appointments etc.) via phone at (920) 926-4200.

Katherine Lorraine Grady is licensed to practice in Wisconsin (license number 9339-123) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1760046981.

Contact Information

Katherine Lorraine Grady, MSW, CAPSW
845 Parkside St,
Ripon, WI 54971-8505
(920) 926-4200
(920) 926-8933



Healthcare Provider's Profile

Full NameKatherine Lorraine Grady
GenderFemale
SpecialityClinical Social Worker
Experience11 Years
Location845 Parkside St, Ripon, Wisconsin
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Katherine Lorraine Grady graduated from medical school in 2013
  NPI Data:
  • NPI Number: 1760046981
  • Provider Enumeration Date: 04/23/2019
  • Last Update Date: 09/01/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 0446687917
  • Enrollment ID: I20200221001155

Medical Identifiers

Medical identifiers for Katherine Lorraine Grady such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1760046981NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
1041C0700XSocial Worker - Clinical 9339-123 (Wisconsin)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Agnesian Healthcare Inc1658289624319

News Archive

Study provides new insights into development of skin-depigmenting disease vitiligo

Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin.

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.

ev3 announces FDA approval of treatment for brain vascular disorder

ev3 today announced that its majority-owned subsidiary Micro Therapeutics has received pre-market application (PMA) approval from the U.S. Food and Drug Administration (FDA) to commercialize its Onyx Liquid Embolic System (Onyx) for the treatment of arterio-venous malformations (AVMs), a vascular disorder in the brain.

Phase II trial finds fostamatinib ineffective in RA patients not responsive to biologic agents

In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.

RaySearch reports net sales of SEK 80.3 M for JANUARY 1 – SEPTEMBER 30, 2011

RaySearch Laboratories: JANUARY 1 - SEPTEMBER 30, 2011. Net sales for the period totaled SEK 80.3 M.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Katherine Lorraine Grady allows following entities to bill medicare on her behalf.
Entity NameAgnesian Healthcare Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346228541
PECOS PAC ID: 1658289624
Enrollment ID: O20031104000263

News Archive

Study provides new insights into development of skin-depigmenting disease vitiligo

Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin.

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.

ev3 announces FDA approval of treatment for brain vascular disorder

ev3 today announced that its majority-owned subsidiary Micro Therapeutics has received pre-market application (PMA) approval from the U.S. Food and Drug Administration (FDA) to commercialize its Onyx Liquid Embolic System (Onyx) for the treatment of arterio-venous malformations (AVMs), a vascular disorder in the brain.

Phase II trial finds fostamatinib ineffective in RA patients not responsive to biologic agents

In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.

RaySearch reports net sales of SEK 80.3 M for JANUARY 1 – SEPTEMBER 30, 2011

RaySearch Laboratories: JANUARY 1 - SEPTEMBER 30, 2011. Net sales for the period totaled SEK 80.3 M.

Read more Medical News

› Verified 1 days ago

Entity NameWaupun Memorial Hospital
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1548248644
PECOS PAC ID: 7618886565
Enrollment ID: O20070523000593

News Archive

Study provides new insights into development of skin-depigmenting disease vitiligo

Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin.

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.

ev3 announces FDA approval of treatment for brain vascular disorder

ev3 today announced that its majority-owned subsidiary Micro Therapeutics has received pre-market application (PMA) approval from the U.S. Food and Drug Administration (FDA) to commercialize its Onyx Liquid Embolic System (Onyx) for the treatment of arterio-venous malformations (AVMs), a vascular disorder in the brain.

Phase II trial finds fostamatinib ineffective in RA patients not responsive to biologic agents

In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.

RaySearch reports net sales of SEK 80.3 M for JANUARY 1 – SEPTEMBER 30, 2011

RaySearch Laboratories: JANUARY 1 - SEPTEMBER 30, 2011. Net sales for the period totaled SEK 80.3 M.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Katherine Lorraine Grady is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Katherine Lorraine Grady, MSW, CAPSW
620 W Brown St,
Waupun, WI 53963-1702

Ph: () -
Katherine Lorraine Grady, MSW, CAPSW
845 Parkside St,
Ripon, WI 54971-8505

Ph: (920) 926-4200

News Archive

Study provides new insights into development of skin-depigmenting disease vitiligo

Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin.

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.

ev3 announces FDA approval of treatment for brain vascular disorder

ev3 today announced that its majority-owned subsidiary Micro Therapeutics has received pre-market application (PMA) approval from the U.S. Food and Drug Administration (FDA) to commercialize its Onyx Liquid Embolic System (Onyx) for the treatment of arterio-venous malformations (AVMs), a vascular disorder in the brain.

Phase II trial finds fostamatinib ineffective in RA patients not responsive to biologic agents

In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.

RaySearch reports net sales of SEK 80.3 M for JANUARY 1 – SEPTEMBER 30, 2011

RaySearch Laboratories: JANUARY 1 - SEPTEMBER 30, 2011. Net sales for the period totaled SEK 80.3 M.

Read more News

› Verified 1 days ago


Social Worker in Ripon, WI

Laurie Ann Rechek, LCSW
Clinical Social Worker
Medicare: Accepting Medicare Assignments
Practice Location: 845 Parkside St, Ripon, WI 54971
Phone: 920-926-4200    Fax: 920-926-8914
Sarah Ann Heyn, MSSW
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 723 Chester Court, Ripon, WI 54971
Phone: 217-235-3877    Fax: 803-356-8580
Racheal Anne Pluim-bergmann, LCSW
Clinical Social Worker
Medicare: Medicare Enrolled
Practice Location: 835 Parkside St, Ripon, WI 54971
Phone: 920-748-3101    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.